Translational Nanobiology Section, Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Nuffield Department of Women's and Reproductive Health, University of Oxford, Women's Centre, John Radcliffe Hospital, Oxford, UK.
J Extracell Vesicles. 2024 Feb;13(2):e12404. doi: 10.1002/jev2.12404.
Extracellular vesicles (EVs), through their complex cargo, can reflect the state of their cell of origin and change the functions and phenotypes of other cells. These features indicate strong biomarker and therapeutic potential and have generated broad interest, as evidenced by the steady year-on-year increase in the numbers of scientific publications about EVs. Important advances have been made in EV metrology and in understanding and applying EV biology. However, hurdles remain to realising the potential of EVs in domains ranging from basic biology to clinical applications due to challenges in EV nomenclature, separation from non-vesicular extracellular particles, characterisation and functional studies. To address the challenges and opportunities in this rapidly evolving field, the International Society for Extracellular Vesicles (ISEV) updates its 'Minimal Information for Studies of Extracellular Vesicles', which was first published in 2014 and then in 2018 as MISEV2014 and MISEV2018, respectively. The goal of the current document, MISEV2023, is to provide researchers with an updated snapshot of available approaches and their advantages and limitations for production, separation and characterisation of EVs from multiple sources, including cell culture, body fluids and solid tissues. In addition to presenting the latest state of the art in basic principles of EV research, this document also covers advanced techniques and approaches that are currently expanding the boundaries of the field. MISEV2023 also includes new sections on EV release and uptake and a brief discussion of in vivo approaches to study EVs. Compiling feedback from ISEV expert task forces and more than 1000 researchers, this document conveys the current state of EV research to facilitate robust scientific discoveries and move the field forward even more rapidly.
细胞外囊泡(EVs)通过其复杂的货物,可以反映其起源细胞的状态,并改变其他细胞的功能和表型。这些特征表明它们具有强大的生物标志物和治疗潜力,这一点已被关于 EVs 的科学出版物数量逐年稳步增长所证明。在 EV 计量学以及对 EV 生物学的理解和应用方面已经取得了重要进展。然而,由于 EV 命名法、与非囊泡细胞外颗粒的分离、表征和功能研究方面的挑战,EV 在从基础生物学到临床应用的各个领域的潜在应用仍存在障碍。为了解决这个快速发展领域中的挑战和机遇,国际细胞外囊泡学会(ISEV)更新了其“细胞外囊泡研究的最低信息”,该信息最初于 2014 年发布,然后分别于 2018 年和 2022 年以 MISEV2014 和 MISEV2023 的形式发布。本文件的目标是为研究人员提供一个最新的快照,介绍从包括细胞培养物、体液和固体组织在内的多种来源中分离和表征 EV 的现有方法及其优缺点。除了介绍 EV 研究基本原理的最新进展外,本文还涵盖了目前正在扩展该领域边界的先进技术和方法。MISEV2023 还包括关于 EV 释放和摄取的新章节以及简要讨论体内研究 EV 的方法。本文件汇集了 ISEV 专家工作组和 1000 多名研究人员的反馈意见,传达了 EV 研究的现状,以促进稳健的科学发现,并使该领域更快地向前发展。